Treatment Registry
TR-0885 ActiveRecorded October 2026

Compounded tirzepatide

Sold by Alinwell · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Alinwell

We earn nothing from this link. It opens Alinwell's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • October 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationThe product FAQ requires 30 days’ notice before the next cycle, while the terms say to cancel at least 48 hours before processing. The applicable deadline is unresolved. Terms separately restrict cancellation of initial prescription orders after provider-network receipt and refunds after medication fulfillment. https://alinwell.com/terms and https://alinwell.com/treatments/tirzepatide
MembershipNot disclosed
Consult feeIncluded in program price; itemized amount is not published. The program includes provider support and the product FAQ states zero consultation charges. https://alinwell.com/treatments/tirzepatide

Recorded from alinwell.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — This program includes compounded medication, provider-directed dosing, secure messaging, check-ins and delivery. Weekly injection is described; the reviewed page does not establish a vial or pen. https://alinwell.com/treatments/tirzepatide
  2. 2. October 2026 — The homepage advertises this program from $166/mo. The terms describe charges every 30 days. The billing-period conflict and starting-price conditions are unresolved; the recurring payment has not been established. https://alinwell.com/ and https://alinwell.com/terms
  3. 3. October 2026 — The terms describe one bundled subscription total including medication and platform/medical-group fees. No separate universal additional membership amount was established. The reviewed pages do not name a dispensing pharmacy or provide a state roster. Telehealth availability remains subject to location and clinician eligibility. https://alinwell.com/terms

2 further notes concern other Alinwell programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0885
Medication category
compounded tirzepatide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Alinwell — compounded tirzepatide (TR-0885). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0885

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.